News
Search EMA's news announcements
Nota sulla lingua indicata
Questa pagina non è disponibile su questo sito web nella lingua selezionata mediante il servizio di traduzione automatica.
Viene mostrata nella versione originale in inglese.
On 29 September 2026, we updated the search paths shown in your browser's address bar to make them easier to read and understand. As a result, links to search results that you previously bookmarked may no longer work. We advise you to carry out your search again.
Results (3899)
Image credit: © tadamichi | stock.adobe.com
PRAC starts review of depression and anxiety medicine Deanxit and a safety signal related to human normal immunoglobulin medicines
NewsHumanPharmacovigilance
The European Medicines Agency's (EMA) office is closed from 18:00 on Friday 30 October until 08:30 on Tuesday 3 November
NewsCorporate
Image credit: © peterschreiber.media | stock.adobe.com
Clinical trial requirements defined for rapid development of Bundibugyo virus vaccines
NewsHumanClinical trialsResearch and developmentVaccines
Image credit: © Marcos Osorio/Stocksy | stock.adobe.com
Six new medicines recommended for approval; another five medicines recommended for extension of their therapeutic indications
NewsHumanMedicines
Once-daily tablet provides an alternative to other oral and injectable GLP-1 medicines
NewsHumanMedicines
Image credit: © Chinnapong | stock.adobe.com
Phased review fast tracks assessment of medicine addressing unmet medical need
NewsHumanInnovationMedicines
Image credit: © Landscapes | stock.adobe.com
Bovilis Lumpyvax helps protect cattle against serious viral infection
NewsVeterinaryVaccines
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting
NewsVeterinary
Image credit: © Felix / peopleimages.com | stock.adobe.com
Technical and regulatory support for preparing clinical trial applications will continue from January 2027
NewsHumanClinical trialsMedicines
Image credit: © tadamichi | stock.adobe.com
PRAC carried out its broad range of responsibilities for managing the safety of medicines
NewsHumanPharmacovigilance